Aron Jaffe
Head of Bleeding Edge, Curie.Bio
Aron Jaffe is a biotech leader at Curie.Bio, where he partners with founders to translate novel biology and technologies into new therapeutics and companies. He was previously Head of Research at Chroma Medicine, building an epigenetic editing pipeline that generated two development candidates, including a lead program now in the clinic. Earlier, he held leadership roles at Novartis, co-discovering the pulmonary ionocyte, and was an Entrepreneur-in-Residence at Third Rock Ventures.
Events Aron Jaffe has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026